ETFs & Funds
Credit Suisse analyst Catherine Arnold upgraded her rating on $
to "Outperform" and raised the price target to $24.
Add a reply...
Latest StockTalks »
people get IRWD breaking news and analysis by email alert.
Get email alerts on IRWD »
Ironwood Pharmaceuticals, Inc.
Get latest price
From other sites
AstraZeneca slips on downgrade worries
at Financial Times (Apr 26, 2016)
First Week of June 17th Options Trading For Ironwood Pharmaceuticals (IRWD)
at Nasdaq.com (Apr 19, 2016)
Why You Shouldn't Bet Against Ironwood Pharmaceuticals (IRWD) Stock
at Zacks.com (Mar 29, 2016)
Commit To Buy Ironwood Pharmaceuticals At $7.50, Earn 24.1% Annualized Using Options
at Nasdaq.com (Feb 19, 2016)
Ironwood Pharmaceuticals is Now Oversold (IRWD)
at Nasdaq.com (Sep 29, 2015)